PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 100 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $223,000 | -71.9% | 58,882 | -62.3% | 0.00% | – |
| Q4 2019 | $795,000 | +37.3% | 156,146 | +36.4% | 0.00% | – |
| Q3 2019 | $579,000 | -17.0% | 114,478 | +1.2% | 0.00% | – |
| Q2 2019 | $698,000 | -73.7% | 113,173 | -80.2% | 0.00% | -100.0% |
| Q1 2019 | $2,656,000 | +452.2% | 572,365 | +400.8% | 0.00% | – |
| Q4 2018 | $481,000 | -30.8% | 114,295 | +3.2% | 0.00% | – |
| Q3 2018 | $695,000 | -19.2% | 110,778 | +3.5% | 0.00% | – |
| Q2 2018 | $860,000 | -36.2% | 107,001 | -40.8% | 0.00% | – |
| Q1 2018 | $1,349,000 | +5.6% | 180,757 | -15.8% | 0.00% | – |
| Q4 2017 | $1,277,000 | -16.9% | 214,623 | +2.8% | 0.00% | – |
| Q3 2017 | $1,537,000 | +37.8% | 208,816 | +27.2% | 0.00% | – |
| Q2 2017 | $1,115,000 | -36.8% | 164,158 | -12.1% | 0.00% | -100.0% |
| Q1 2017 | $1,764,000 | +1.8% | 186,812 | -6.8% | 0.00% | 0.0% |
| Q4 2016 | $1,732,000 | +273.3% | 200,458 | +173.4% | 0.00% | – |
| Q3 2016 | $464,000 | +50.6% | 73,316 | +0.5% | 0.00% | – |
| Q2 2016 | $308,000 | -10.2% | 72,956 | -7.2% | 0.00% | – |
| Q1 2016 | $343,000 | -25.9% | 78,656 | +4.1% | 0.00% | – |
| Q4 2015 | $463,000 | +309.7% | 75,570 | +282.3% | 0.00% | – |
| Q3 2015 | $113,000 | -59.1% | 19,767 | -46.4% | 0.00% | – |
| Q2 2015 | $276,000 | +318.2% | 36,855 | +233.7% | 0.00% | – |
| Q1 2015 | $66,000 | +175.0% | 11,046 | +242.4% | 0.00% | – |
| Q4 2014 | $24,000 | +41.2% | 3,226 | +0.8% | 0.00% | – |
| Q3 2014 | $17,000 | -37.0% | 3,200 | -49.6% | 0.00% | – |
| Q2 2014 | $27,000 | – | 6,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|